US reports first case of Clade I mpox in California
A person in California has tested positive for the emerging strain, which can cause a more serious illness.
Related Articles
Seattle system uses grants to form healthy community partnerships
Virginia Mason Franciscan Health distributed $1.7 million among 24 nonprofit organizations collaborating to better the health of their communities.
How ADHD May Influence a Child’s Weight
MONDAY, Nov. 11, 2024 (HealthDay News) — Attention-deficit/hyperactivity disorder can influence a child’s weight in ways that will shape their long-term health
American Heart Association Scientific Session Articles
Explore special articles published online first to coincide with presentations at AHA American Heart Association’s Annual Scientific Session.
Patient-Directed Education to Promote Deprescribing
This pragmatic nonrandomized multisite clinical trial examines the effectiveness of patient-directed educational materials provided before primary care appointments in promoting deprescribing for low-benefit and high-risk…
Bystander Use of Opioid Overdose Antidote Naloxone Is on the Rise
Research has found that in nearly 40% of opioid overdose deaths, documented bystanders could have potentially administered the lifesaving medicine naloxone. But in a promising…
Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections
Nature Medicine – Next-generation metagenomic testing increases the accuracy and sensitivity of the etiology of central nervous system infections in hospitalized patients.
Polygenic Risk Scores for Coronary Heart Disease
Risk prediction to inform strategies for the primary prevention of cardiovascular disease is universally recommended by clinical practice guidelines in the US and worldwide.1,2 A…
Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores
This study aims to characterize the individual-level agreement of polygenic risk scores for coronary heart disease that perform similarly at the population level.
Rapid Initiation of SGLT2 Inhibitors Improves Cost-Effectiveness of Therapy, with Ankeet Bhatt, MD, MBA
Ankeet Bhatt, MD, MBA, discusses a study he led from AHA 2024 examining the cost-effectiveness of dapagliflozin based on how soon therapy was initiated following…
